Stay updated on Ipragliflozin vs Sitagliptin in T2DM with SU+Met Clinical Trial

Sign up to get notified when there's something new on the Ipragliflozin vs Sitagliptin in T2DM with SU+Met Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ipragliflozin vs Sitagliptin in T2DM with SU+Met Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Revision updated from v3.6.2 to v3.6.3, signaling a minor site maintenance release. This change does not modify the displayed study information or navigation.
    Difference
    0.1%
    Check dated 2026-07-05T14:39:48.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The page version was updated from v3.6.0 to v3.6.2, signaling a new build of the page. The underlying study details appear unchanged.
    Difference
    0.1%
    Check dated 2026-06-28T08:59:37.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    Removed the related topics header and the entries for Type 2 diabetes and MedlinePlus Genetics from the page's related topics section. This changes the navigational links shown to users but does not alter the study's primary data or descriptions.
    Difference
    0.2%
    Check dated 2026-06-20T22:15:39.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    Recruitment is now indicated as closed ('No longer looking for participants'), reflecting that the study is not enrolling any more participants. The update also adjusts the Intervention/Treatment label and adds a page revision tag (Revision: v3.6.0).
    Difference
    0.4%
    Check dated 2026-06-13T17:39:58.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    Footer revision updated from v3.5.4 to v3.5.5. This indicates a minor maintenance update to the study record page.
    Difference
    0.1%
    Check dated 2026-06-06T14:02:47.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The page now lists a newer site revision label 'Revision: v3.5.4', replacing 'Revision: v3.5.3'. This reflects a deployment update to the ClinicalTrials.gov interface rather than a change to the study information.
    Difference
    0.1%
    Check dated 2026-05-15T23:44:15.000Z thumbnail image

Stay in the know with updates to Ipragliflozin vs Sitagliptin in T2DM with SU+Met Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ipragliflozin vs Sitagliptin in T2DM with SU+Met Clinical Trial page.